Ginkgo Bioworks
Ginkgo Bioworks is a leading synthetic biology company that partners with organizations across various industries to harness the power of biology. Their mission is to make biology easier to engineer, enabling the development of innovative solutions in agriculture, biopharma, industrial biotechnology, and more. Ginkgo's platform combines advanced automation, data analytics, and a vast library of genetic assets to accelerate research and development, optimize production processes, and reduce costs. They are revolutionizing industrial processes with biological solutions that lower costs, open new markets, valorize waste streams, and create sustainable supply chains.
Ginkgo Bioworks
27 Drydock Avenue, 8th Floor, Boston, MA 02210
What We Do
Ginkgo Bioworks offers comprehensive R&D services across multiple sectors, including agriculture, biopharma, industrial biotechnology, and more. Their services include strain optimization, fermentation process development, and lab-to-field testing.
Design a multi-layered biosecurity program to protect the things you care about the most.
Scale up your fermentation from 250 mL to >50,000 L on our platform.
Screen millions of strain variants to optimize for your application.
Engineer and optimize biosynthetic pathways for small molecules.
Discover and optimize the production of novel proteins for a variety of applications.
Key People
Co-Founder & CEO
AI Researcher
AI Developer
AI Developer
Co-Founder & President
Co-Founder
News & Updates
Ginkgo Bioworks announced the launch of Ginkgo Datapoints, a platform for generating data to train AI models, enhancing their capabilities in synthetic biology.
Ginkgo Bioworks introduced their Model API, a tool for AI research and development in synthetic biology.
Ginkgo Bioworks is leveraging big data and AI to revolutionize enzyme engineering, enhancing the efficiency and specificity of enzyme design.
Ginkgo Bioworks announced the opening of Bioworks7, expanding their capacity in biopharmaceuticals, biomanufacturing, and mammalian programming for therapeutic applications.
Ginkgo Bioworks acquired Altar and Circularis to enhance capabilities in adaptive laboratory evolution, circular RNA, and promoter screening.
Ginkgo Bioworks helped a partner reduce the amount of exogenous enzyme needed in their manufacturing process by ten-fold, saving millions in input costs through enzyme discovery services.